KLP Kapitalforvaltning AS bought a new stake in Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 75,000 shares of the real estate investment trust's stock, valued at approximately $1,271,000.
Several other institutional investors have also recently made changes to their positions in HR. Smartleaf Asset Management LLC increased its stake in Healthcare Realty Trust by 59.0% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,650 shares of the real estate investment trust's stock worth $27,000 after purchasing an additional 612 shares during the period. Pacer Advisors Inc. increased its stake in Healthcare Realty Trust by 1.1% in the 4th quarter. Pacer Advisors Inc. now owns 70,776 shares of the real estate investment trust's stock worth $1,200,000 after buying an additional 786 shares during the period. Park Avenue Securities LLC increased its stake in Healthcare Realty Trust by 4.1% in the 4th quarter. Park Avenue Securities LLC now owns 20,193 shares of the real estate investment trust's stock worth $342,000 after buying an additional 793 shares during the period. Consolidated Portfolio Review Corp lifted its holdings in Healthcare Realty Trust by 1.5% during the 4th quarter. Consolidated Portfolio Review Corp now owns 55,333 shares of the real estate investment trust's stock valued at $938,000 after buying an additional 808 shares in the last quarter. Finally, Blue Trust Inc. boosted its position in Healthcare Realty Trust by 130.3% in the 4th quarter. Blue Trust Inc. now owns 1,635 shares of the real estate investment trust's stock valued at $30,000 after buying an additional 925 shares during the period.
Healthcare Realty Trust Price Performance
Healthcare Realty Trust stock traded down $0.21 during trading hours on Thursday, reaching $16.65. The stock had a trading volume of 2,784,882 shares, compared to its average volume of 3,266,514. The company has a market cap of $5.84 billion, a price-to-earnings ratio of -9.35 and a beta of 0.97. The business's 50 day moving average price is $16.67 and its 200-day moving average price is $17.18. Healthcare Realty Trust Incorporated has a 52 week low of $13.64 and a 52 week high of $18.90.
Healthcare Realty Trust (NYSE:HR - Get Free Report) last posted its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.40 EPS for the quarter, beating analysts' consensus estimates of $0.39 by $0.01. Healthcare Realty Trust had a negative net margin of 51.60% and a negative return on equity of 11.20%. The company had revenue of $309.77 million during the quarter, compared to analysts' expectations of $303.81 million. During the same quarter in the prior year, the company posted $0.39 earnings per share. Healthcare Realty Trust's revenue for the quarter was down 6.3% compared to the same quarter last year. On average, sell-side analysts forecast that Healthcare Realty Trust Incorporated will post 1.59 EPS for the current fiscal year.
Healthcare Realty Trust Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 19th. Investors of record on Monday, March 3rd were paid a dividend of $0.31 per share. The ex-dividend date was Monday, March 3rd. This represents a $1.24 annualized dividend and a yield of 7.45%. Healthcare Realty Trust's dividend payout ratio (DPR) is -69.66%.
Analyst Ratings Changes
HR has been the topic of a number of research reports. StockNews.com lowered shares of Healthcare Realty Trust from a "hold" rating to a "sell" rating in a research report on Thursday, March 27th. Scotiabank reduced their price objective on Healthcare Realty Trust from $18.00 to $17.00 and set a "sector perform" rating on the stock in a report on Tuesday, February 25th. Wells Fargo & Company lowered their target price on Healthcare Realty Trust from $17.00 to $16.00 and set an "underweight" rating for the company in a report on Monday, March 10th. JPMorgan Chase & Co. lowered Healthcare Realty Trust from an "overweight" rating to a "neutral" rating and set a $19.00 price target on the stock. in a research note on Friday, December 20th. Finally, Wedbush reaffirmed an "outperform" rating and issued a $16.00 price objective on shares of Healthcare Realty Trust in a research note on Thursday, February 20th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $17.00.
Check Out Our Latest Analysis on Healthcare Realty Trust
About Healthcare Realty Trust
(
Free Report)
Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.
Further Reading
Before you consider Healthcare Realty Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.
While Healthcare Realty Trust currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
